Cardiology

Noncalcified coronary plaque burden higher in people with HIV

People living with human immunodeficiency virus (HIV) and without known cardiovascular disease have two to three times the noncalcified coronary plaque burden of non-HIV healthy volunteers, according to a study from Canada ...

HIV & AIDS

Diabetes drug may be a new weapon against HIV

A team led by scientists at the UNC School of Medicine discovered an important vulnerability of the AIDS-causing retrovirus HIV, and has shown in preclinical experiments that a widely used diabetes drug, metformin, seems ...

HIV & AIDS

Vaccine regimen fails to prevent HIV-1 infection in South Africa

(HealthDay)—A canarypox-protein HIV vaccine regimen (ALVAC-HIV) plus bivalent subtype C gp120-MF59 adjuvant does not prevent HIV-1 infection among adults in South Africa, according to a study published in the March 25 issue ...

HIV & AIDS

HIV: An antidiabetic drug to reduce chronic inflammation

Metformin, a drug used to treat type-2 diabetes, could help reduce chronic inflammation in people living with HIV (PLWH) who are being treated with antiretroviral therapy (ART), according to researchers at the University ...

HIV & AIDS

Disappointment and hope from two HIV prevention trials

An antibody infusion being tested for preventing HIV does not seem to thwart most infections—but its success against certain strains of the virus suggests researchers are on the right track.

Medical research

Increased weight gain with HIV-therapy TAF medication

Research team Inselspital and University of Bern found an above average weight gain associated with increase blood lipids after switching HIV-therapy from TDF to TAF. Additional individual counseling will be necessary to ...

page 21 from 40